XSHE
002100
Market cap1.34bUSD
Dec 05, Last price
6.96CNY
1D
0.58%
1Q
4.82%
Jan 2017
-22.41%
IPO
272.19%
Name
Tecon Biology Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Tecon Biology Co.Ltd engages in the research, development, production, and sale of animal feed in China and internationally. The company offers chicken, pig, ruminant, aquatic, and other feed products; and protein feeds and edible oils, as well as breeds piglets and pigs, and processes and sells meat. It also produces soybean, sunflower, rapeseed, and cottonseed oils and meals. In addition, the company manufactures and sells veterinary biological products. Further, it offers loan, bill acceptance, trade financing, project financing, credit, and other financing guarantees, as well as provides commodity financing supervision services. The company was formerly known as Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd. and changed its name to Tecon Biology Co.Ltd in June 2016. Tecon Biology Co.Ltd was founded in 1993 and is based in Urumqi, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||